More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Diamorphine shortage causing former heroin users to relapse for first time in a decade, charities warn With all strengths of diamorphine injections currently out of stock, charities have said patients are returning to using heroin.…
Welsh government plans to expand PrEP access to community pharmacies The Welsh government's draft action plan outlines 26 recommendations to reduce HIV transmission and improve the lives of people with HIV.…
First two antimicrobial drugs funded by NHS subscription payment scheme to be given to patients The NHS England payment scheme is aimed to incentivise antimicrobial drug innovation.…
Deprivation and ethnicity linked with lower anticoagulation prescribing for atrial fibrillation, study reveals Researchers found that, compared with white people, black people were 22% less likely to be prescribed an oral anticoagulant and those from other ethnic minorities were 24% less likely.…
Shifting the scales: a promising new era for weight-loss drugs With obesity rates continuing to rise, the need for pharmacological options to help patients safely lose weight is urgent, but there are several promising drugs on the horizon.…
Whole-genome sequencing is ‘feasible’ for screening in primary care, research suggests Presenting their findings, study authors said genomic sequencing in primary care could change the way patients and their families are managed by GPs.…
Pharmacies and opioid dependency: working together to better support recovery One patient in particular led Rachel Britton to discover and develop the role of pharmacists and pharmacy technicians in helping people with opioid dependency.…
Miscarriage: causes, prevention and counselling Guidance on how pharmacists can provide women with practical advice and support during pregnancy and in the event of a miscarriage.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
